Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|February 27, 2019
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancerMercedes Marín-Aguilera, Òscar Reig, Maria Milà-Guasch, et al.
Cancers|October 14, 2022
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and DocetaxelNatalia Jiménez, Òscar Reig, Mercedes Marín-Aguilera, et al.
Molecular Cancer|October 22, 2014
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulationsFrancesca Mateo, Oscar Meca-Cortés, Toni Celià-Terrassa, et al.
The Pediatric Infectious Disease Journal|October 17, 2024
Impact of the COVID-19 Pandemic on Pediatric Bacterial Community-acquired Pneumonia: A Multicenter Retrospective Study in Madrid, SpainDavid Aguilera-Alonso, Juan Sánchez-Cañete, Leyre Ventura McArdle, et al.
JAMA Oncology|April 27, 2023
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and PertuzumabAdrienne G Waks, Esther R Ogayo, Laia Paré, et al.
BMC Infectious Diseases|March 30, 2019
Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditisMaría Ercibengoa, Miguel Angel Goenaga, Carmen Ardanuy, et al.
International Journal of Molecular Sciences|July 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN ExpressionMarta Garcia de Herreros, Natalia Jiménez, Joan Padrosa, et al.
Ebiomedicine|March 6, 2024
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studiesBenedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, et al.
Journal of the National Cancer Institute|December 28, 2022
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, et al.
Ebiomedicine|January 6, 2022
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancerAleix Prat, Valentina Guarneri, Tomás Pascual, et al.
Pageof 16